Early Feasibility Study

JACKSONVILLE, Fla., July 30, 2026 Medical Microinstruments (MMI) announced that the U.S. Food and Drug Administration (FDA) has approved...

ATLANTA, July 7, 2026 Nyra Medical, Inc. has announced the enrollment of the first patient in its ENHANCE Early...

SAN CARLOS, Calif., June 30, 2026 BeOne Medicines has announced positive topline results from the Phase 3 MANGROVE clinical...

MINNEAPOLIS, Minn., June 29, 2026 Laplace Interventional has reached a significant regulatory milestone after receiving U.S. Food and Drug...

SANTA CLARA, Calif., June 17, 2026 VahatiCor, Inc., a medical device company focused on developing innovative therapies for coronary...

KENNEWICK, Wash., June 5, 2026 Vivos Inc. announced the submission of an Early Feasibility Investigational Device Exemption (IDE) application...